Objectives: Strategies for oxygen therapy for preterm infants, such as the Vermont-Oxford's ‘Breathsavers' guidelines, seek to strike a balance between the potential risks of the extremes of hyperoxia and hypoxia in preterm infants. Using an algorithm based on those guidelines, we aimed to compare the proportion of time spent within the SpO2 target range during algorithm-based management of oxygen delivery compared with routine nursing care. Study Design: In a randomised crossover trial, maintenance of SpO2 over a 4-hour period during routine care was compared with algorithm-based control (administered by a dedicated research nurse). SpO2 target (88-92%) and alarm limits (86-94%) were identical in both arms. Infants <32 weeks' gestation were eligible if having >8 desaturations episodes to <85%/4 h while receiving continuous positive airway pressure/synchronised intermittent mandatory ventilation. Data was recorded via the Powerlab system from Masimo oximeters and Babylog 8000+ ventilators. Results: 16 infants with a gestation of 26.7 ± 1.3 weeks (mean ± SD) and birth weight 901 ± 193 g were studied at a postmenstrual age of 30.5 ± 2.4 weeks. The percentage of time spent within target range was 34.6 ± 28.5% during routine care versus 38.3 ± 29.3% during algorithm-based care (p = 0.23). Compliance with alarm limits was 58.4 ± 21.8% during routine versus 64.7 ± 22.1% for algorithm-based care (p = 0.091). The frequency of desaturations, episode severity or number of FiO2 adjustments did not differ between the two care strategies. Conclusions: The observation that algorithm-based control did not improve time spent within the SpO2 target and alarm limits suggests nursing care has reached an optimum in the unit studied. Our finding indicates that significant modifications to the algorithm are likely to be necessary to improve target range compliance. © 2014 S. Karger AG, Basel

1.
Saugstad OD, Aune D: Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies. Neonatology 2014;105:55-63.
2.
Stenson BJ: Oxygen targets for preterm infants. Neonatology 2013;103:341-345.
3.
Cross KW: Cost of preventing retrolental fibroplasia? Lancet 1973;2:954-956
4.
Campbell K: Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med J Aust 1951;2:48-50.
5.
Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM: Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003;349:959-967.
6.
Bose CL, Dammann CEL, Laughon MM: Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Childhood Fetal Neonatal Ed 2008;93:F455-F461.
7.
York JR, Landers S, Kirby RS, Arbogast PG, Penn JS: Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol 2004;24:82-87.
8.
Di Fiore JM, Bloom JN, Orge F, Schutt A, Schluchter M, Cheruvu VK, et al: A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 2010;157:69-73.
9.
Thomas WJ, Rauser M, Dovich JA, Dustin L, Flaxel CJ: Oxygen saturation in premature infants at risk for threshold retinopathy of prematurity. Eur J Ophthalmol 2011;21:189-193.
10.
Veasey SC, Davis CW, Fenik P, Zhan G, Hsu Y-J, Pratico D, et al: Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 2004;27:194-201.
11.
Row BW, Kheirandish L, Neville JJ, Gozal D: Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002;52:449-453.
12.
Hagadorn JI, Furey AM, Nghiem T-H, Schmid CH, Phelps DL, Pillers D-AM, et al: Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks' gestation: the AVIOx study. Pediatrics 2006;118:1574-1582.
13.
Vijayakumar E, Ward GJ, Bullock CE, Patterson ML: Pulse oximetry in infants of <1,500 gm birth weight on supplemental oxygen: a national survey. J Perinatol 1997;17:341-345.
14.
Ford SP, Leick-Rude MK, Meinert KA, Anderson B, Sheehan MB, Haney BM, et al: Overcoming barriers to oxygen saturation targeting. Pediatrics 2006;118(suppl 2):S177-S186.
15.
Chow LC, Wright KW, Sola A; CSMC Oxygen Administration Study Group: Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003;111:339-345.
16.
Coe K, Butler M, Reavis N, Klinepeter ME, Purkey C, Oliver T, et al: Special Premie Oxygen Targeting (SPOT): a program to decrease the incidence of blindness in infants with retinopathy of prematurity. J Nurs Care Qual 2006;21:230-235.
17.
Ellsbury DL, Ursprung R: Comprehensive Oxygen Management for the Prevention of Retinopathy of Prematurity: the pediatrix experience. Clin Perinatol 2010;37:203-215.
18.
Claure N, Gerhardt T, Everett R, Musante G, Herrera C, Bancalari E: Closed-loop controlled inspired oxygen concentration for mechanically ventilated very low birth weight infants with frequent episodes of hypoxemia. Pediatrics 2001;107:1120-1124.
19.
Urschitz MS, Horn W, Seyfang A, Hallenberger A, Herberts T, Miksch S, et al: Automatic control of the inspired oxygen fraction in preterm infants: a randomized crossover trial. Am J Respir Crit Care Med 2004;170:1095-1100.
20.
Claure N, Bancalari E, D'Ugard C, Nelin L, Stein M, Ramanathan R, et al: Multicenter crossover study of automated control of inspired oxygen in ventilated preterm infants. Pediatrics 2011;127:e76-e83.
21.
van der Eijk AC, Dankelman J, Schutte S, Simonsz HJ, Smit BJ: An observational study to quantify manual adjustments of the inspired oxygen fraction in extremely low birth weight infants. Acta Paediatr 2012;101:e97-e104.
22.
Claure N, D'Ugard C, Bancalari E: Automated adjustment of inspired oxygen in preterm infants with frequent fluctuations in oxygenation: a pilot clinical trial. J Pediatr 2009;155:640-645.e1-e2.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.